Chemoinformaics analysis of 4-Beta-D-Glucopyranosyloxybenzyl-Alcohol
| Molecular Weight | 286.28 | nRot | 4 |
| Heavy Atom Molecular Weight | 268.136 | nRig | 12 |
| Exact Molecular Weight | 286.105 | nRing | 2 |
| Solubility: LogS | -1.272 | nHRing | 1 |
| Solubility: LogP | -1.512 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 1 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 6 |
| nHA | 7 | APOL | 39.3263 |
| nHD | 5 | BPOL | 21.5297 |
| QED | 0.45 |
| Synth | 3.321 |
| Natural Product Likeliness | 1.795 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.018 |
| HIA | 0.823 |
| CACO-2 | -5.386 |
| MDCK | 0.000411957 |
| BBB | 0.538 |
| PPB | 0.206887 |
| VDSS | 0.414 |
| FU | 0.616369 |
| CYP1A2-inh | 0.032 |
| CYP1A2-sub | 0.038 |
| CYP2c19-inh | 0.012 |
| CYP2c19-sub | 0.242 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.081 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.316 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0.038 |
| CL | 1.699 |
| T12 | 0.539 |
| hERG | 0.044 |
| Ames | 0.226 |
| ROA | 0.049 |
| SkinSen | 0.048 |
| Carcinogencity | 0.693 |
| EI | 0.021 |
| Respiratory | 0.014 |
| NR-Aromatase | 0.025 |
| Antiviral | Yes |
| Prediction | 0.824056 |